Illumina (TICKER: ILMN) Benchmark And Performance Data

there are 12 of samples in the benchmark for Illumina in year 2022 in 2022. The total inventory for Illumina was $431,000,000.00 in 2021. The total inventory for Illumina was $386,000,000.00 in 2018. The total inventory for Illumina was $372,000,000.00 in 2020. The total inventory for Illumina was $359,000,000.00 in 2019. The total inventory for Illumina was $333,000,000.00 in 2017. The total inventory for Illumina was $300,000,000.00 in 2016. The total inventory for Illumina was $270,777,000.00 in 2015. The total inventory for Illumina was $191,144,000.00 in 2014. The total inventory for Illumina was $158,718,000.00 in 2012. The total inventory for Illumina was $154,099,000.00 in 2013. The sales, general, and administrative (SGA) for Illumina was $941,000,000.00 in 2020. The sales, general, and administrative (SGA) for Illumina was $835,000,000.00 in 2019. The sales, general, and administrative (SGA) for Illumina was $794,000,000.00 in 2018. The sales, general, and administrative (SGA) for Illumina was $674,000,000.00 in 2017. The sales, general, and administrative (SGA) for Illumina was $584,000,000.00 in 2016. The sales, general, and administrative (SGA) for Illumina was $516,000,000.00 in 2015. The sales, general, and administrative (SGA) for Illumina was $466,283,000.00 in 2014. The sales, general, and administrative (SGA) for Illumina was $381,040,000.00 in 2013. The sales, general, and administrative (SGA) for Illumina was $285,991,000.00 in 2012. The sales, general, and administrative (SGA) for Illumina was $2,092,000,000.00 in 2021. The sales, general, and administrative (SGA) for Illumina was $$1,297,000,000 in 2022. The revenue volatility for Illumina was 15.30% in 2022. The market capitalization for Illumina was $69,088,660,000.00 in 2012. The market capitalization for Illumina was $63,477,965,000.00 in 2013. The market capitalization for Illumina was $59,462,772,000.00 in 2014. The market capitalization for Illumina was $54,886,399,403.00 in 2015. The market capitalization for Illumina was $36,742,900,000.00 in 2019. The market capitalization for Illumina was $31,806,060,000.00 in 2018. The market capitalization for Illumina was $30,011,267,000.00 in 2017. The market capitalization for Illumina was $29,642,169,000.00 in 2020. The market capitalization for Illumina was $28,962,956,000.00 in 2016. The market capitalization for Illumina was $21,731,424,000.00 in 2021. The market capitalization for Illumina was $$22,901,000,000 in 2022. The gross revenue for Illumina was $4,526,000,000.00 in 2021. The gross revenue for Illumina was $3,543,000,000.00 in 2019. The gross revenue for Illumina was $3,333,000,000.00 in 2018. The gross revenue for Illumina was $3,239,000,000.00 in 2020. The gross revenue for Illumina was $2,752,000,000.00 in 2017. The gross revenue for Illumina was $2,398,000,000.00 in 2016. The gross revenue for Illumina was $2,220,000,000.00 in 2015. The gross revenue for Illumina was $1,861,358,000.00 in 2014. The gross revenue for Illumina was $1,421,178,000.00 in 2013. The gross revenue for Illumina was $1,148,516,000.00 in 2012. The gross revenue for Illumina was $$4,584,000,000 in 2022. The gross margin for Illumina was $7.72% in 2022. The days sales outstanding for Illumina was 53 days in 2022. The days payable outstanding for Illumina was 71 days in 2022. The days of inventory for Illumina was $113 in 2022. The cost of goods sold (COGS) for Illumina was 35.17% in 2022. The cost of goods sold (COGS) for Illumina was $926,000,000.00 in 2017. The cost of goods sold (COGS) for Illumina was $732,000,000.00 in 2016. The cost of goods sold (COGS) for Illumina was $671,000,000.00 in 2015. The cost of goods sold (COGS) for Illumina was $563,648,000.00 in 2014. The cost of goods sold (COGS) for Illumina was $509,291,000.00 in 2013. The cost of goods sold (COGS) for Illumina was $374,988,000.00 in 2012. The cost of goods sold (COGS) for Illumina was $1,372,000,000.00 in 2021. The cost of goods sold (COGS) for Illumina was $1,076,000,000.00 in 2019. The cost of goods sold (COGS) for Illumina was $1,036,000,000.00 in 2020. The cost of goods sold (COGS) for Illumina was $1,033,000,000.00 in 2018. The cost of goods sold (COGS) for Illumina was $$1,612,000,000 in 2022. The cash to cash cycle time for Illumina was 95 in 2022. The annual percentage growth rate of Illumina was -0.01% in 2022. Illumina in its benchmark peer group, had rank 7 for gross revenue in 2022. Illumina in its benchmark peer group, had rank 6 for cash to cash cycle time in 2022. Illumina in its benchmark peer group, had rank 5 for sales growth in 2022. Illumina in its benchmark peer group, had rank 5 days for days sales outstanding in 2022. Illumina in its benchmark peer group, had rank 10 days for days of inventory in 2022. Illumina in its benchmark peer group, had rank 1 for cost of goods sold as a percent of revenue in 2022. Illumina headquarters region is West. Illumina has ticker symbol ILMN. Illumina has the following profile: Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test.. Illumina has primary indstury Diagnostics & Research. Illumina had a $$1,125,000,000 gap between actual performance and next performance rank for gross revenue in competitive benchmarking in 2022. Illumina had Revvity, Inc., and Danaher, and Thermo Fisher Scientific Inc., and Laboratory Corp. of America, and IQVIA Holdings, and Illumina, and Charles River Laboratories International, and Quest Diagnostics, and Agilent Technologies, and Mettler-Toledo International, and IDEXX Laboratories, and Waters benchmark peer companies for its SIC code in 2022. Illumina had 38 days gap between actual performance and next performance rank for cash to cash in competitive benchmarking in 2022. Illumina had 3 days gap between actual performance and next performance rank for days sales outstanding in competitive benchmarking in 2022. Illumina had 28 days gap between actual performance and next performance rank for days of inventory in competitive benchmarking in 2022. Illumina had 11.63% gap between actual performance and next performance rank for gross margin in competitive benchmarking in 2022. Illumina had 10,260 number of employees in 2022. Illumina had 1.45% gap between actual performance and next performance rank for sales volatility in competitive benchmarking in 2022. Illumina had 0.01% gap between actual performance and next performance rank for sales growth in competitive benchmarking in 2022. Illumina had 0.00% gap between actual performance and next performance rank for cost of goods sold as a percent of revenue in competitive benchmarking in 2022. Illumina can reduce overall cost by $$241,000,000 by improving both COGS and SGA to next benchmark tier in 2022. Illumina can reduce inventory with practices including SKU Reduction in 2022. Illumina can reduce inventory with practices including Reduce Manufacturing Latency in 2022. Illumina can reduce inventory with practices including Forecast Accuracy in 2022. Illumina can reduce inventory with practices including Demand Shaping in 2022. Illumina can reduce days sales outstanding with practices including in 2022. Illumina can increase sales revenue by $$1,125,000,000 improving sales performance to next benchmark tier in 2022. Illumina can increase revenue growth by $$0 by improving growth performance to next benchmark tier in 2022. Illumina can increase overall revenue by $$1,125,000,000 by improving both growth and sales performance to next benchmark tier in 2022. Illumina can increase days payables outstanding with practices including in 2022. Illumina can increase days payables outstanding by $0 days by increasing days payables outstanding to next benchmark tier in 2022. Illumina can improve total financial performance by $$1,747,000,000 by improving revenue, costs, and working capital in 2022. Illumina can decrease overall working capital by $$381,000,000 by improving inventory, payables and receivables to next benchmark tier in 2022. Illumina can decrease inventory days by $345,000,000 days by reducing inventory days to next benchmark tier in 2022. Illumina can decrease days sales outstanding by $35,000,000 days by reducing days sales outstanding to next benchmark tier in 2022. Illumina can accelerate revenue growth practices including Revenue-optimized Planning in 2022. Illumina can accelerate revenue growth practices including Pricing Optimization in 2022. Illumina can accelerate revenue growth practices including Accelerate Design Pipeline in 2022. 96 days was the measured parity or middle performance level for cash to cash cycle time in Illumina's peer group in 2022. 86 days was the measured parity or middle performance level for days of inventory in Illumina's peer group in 2022. 57 days was the measured advantage or top third performance level for cash to cash cycle time in Illumina's peer group in 2022. 55 days was the measured parity or middle performance level for days sales outstanding in Illumina's peer group in 2022. 50 days was the measured advantage or top third performance level for days sales outstanding in Illumina's peer group in 2022. 46 days was the measured advantage or top third performance level for days of inventory in Illumina's peer group in 2022. 45.64% was the measured parity or middle performance level for cost of goods sold as a percent of revenue in Illumina's peer group in 2022. 43 days was the measured superior or top ten performance level for days sales outstanding in Illumina's peer group in 2022. 41 days was the measured superior or top ten performance level for cash to cash cycle time in Illumina's peer group in 2022. 40.67% was the measured advantage or top third performance level for cost of goods sold as a percent of revenue in Illumina's peer group in 2022. 39.80% was the measured superior or top ten performance level for cost of goods sold as a percent of revenue in Illumina's peer group in 2022. 28.62% was the measured superior or top ten performance level for gross margin in Illumina's peer group in 2022. 13.85% was the measured parity or middle performance level for sales volatility in Illumina's peer group in 2022. 13.30% was the measured advantage or top third performance level for sales volatility in Illumina's peer group in 2022. 11.86% was the measured superior or top ten performance level for sales volatility in Illumina's peer group in 2022. 11 days was the measured superior or top ten performance level for days of inventory in Illumina's peer group in 2022. 0.08% was the measured superior or top ten performance level for sales growth in Illumina's peer group in 2022. -0.04% was the measured parity or middle performance level for sales growth in Illumina's peer group in 2022. -0.00% was the measured advantage or top third performance level for sales growth in Illumina's peer group in 2022. $25.41% was the measured advantage or top third performance level for gross margin in Illumina's peer group in 2022. $19.35% was the measured parity or middle performance level for gross margin in Illumina's peer group in 2022. $$5,708,000,000 was the measured parity or middle performance level for gross revenue in Illumina's peer group in 2022. $$29,812,000,000 was the measured superior or top ten performance level for gross revenue in Illumina's peer group in 2022. $$13,052,000,000 was the measured advantage or top third performance level for gross revenue in Illumina's peer group.